LeNano Diagnostics is an Ontario Canada-based medical device innovator in the in-vitro Diagnostics (IVD) industry. The company focuses on delivering state-of-the-art solutions for point-of-care biomarker testing that for near-patient and home use, suitable for telemedicine.
Our unique biomedical sensor platforms based on nanostructures are innovative state-of-the-art solutions for medical applications, particularly in diagnosis of heart diseases through quick and accurate measurement of cardiac biomarkers.
Our company, located in Mississauga and Waterloo Ontario Canada, collaborates with the Department of Chemistry & Waterloo Institute for Nanotechnology (WIN) at the University of Waterloo to translate scientific achievements with credible opinions.
The R&D scientists and engineers specialized in biomedical engineering and nanomaterial science, together with experts in medical device manufacturing and experienced sales & marking specialists in our team, are actively working together to drive the project forward, bringing the ground-breaking products to the IVD market.